BioCentury
ARTICLE | Company News

Affibody, GE in deal for HER2-targeted PET imaging agent

June 8, 2012 12:28 AM UTC

Affibody AB (Stockholm, Sweden) partnered with GE Healthcare to develop a PET imaging agent for breast and gastric cancer that targets epidermal growth factor receptor 2 ( EGFR2; HER2; ErbB2; neu). Th...